ProCE Banner Activity

Understanding and Managing the Toxicity Profile of New Agents Targeting EGFR Exon 20 Insertions in Patients With Advanced NSCLC

Slideset Download
Download these slides from a live symposium at ONS 2022 featuring review of the toxicity profiles of novel therapies available for the treatment of EGFR ex20ins–positive disease, along with guidance for nurses on best practices for monitoring and management of adverse events and patient education.

Released: April 29, 2022

Expiration: April 28, 2023

No longer available for credit.

Share

Faculty

Marianne Davies

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Takeda Pharm USA

Faculty Disclosure

Primary Author

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP, FAAN, has no conflicts of interest to report.